Target intelligence / Profile preview

Erythrocyte membrane proteins

Molecular classification
Other, Enzyme, Transporter, Receptor, Ion channel, Structural protein
01

Overview

Erythrocyte membrane proteins are a large and functionally diverse group of proteins embedded in or associated with the red blood cell plasma membrane[2][5][1]. They include transmembrane transporters (such as band 3/anion exchanger 1 and Rh proteins), gas and ion channels (e.g., PIEZO1, aquaporin 1), adhesion molecules, structural proteins (spectrin, ankyrin, protein 4.1R), and receptors responsible for blood group antigenicity (glycophorins, Duffy antigen, Kell, etc.)[2][5][1][3]. Collectively, they ensure membrane integrity, deformability, gas exchange, immune recognition, and homeostasis. Mutations or deficiencies in specific erythrocyte membrane proteins result in clinically significant hemolytic and membrane disorders.

Other names
Red cell membrane proteinsRBC membrane proteinserythrocyte surface proteins
02

Biological functions

Membrane structure and shape determinationCell deformability and flexibilityGas exchange (CO₂/O₂ transport)Ion and water transportAdhesion and anti-adhesionAntigenic determination (blood group antigens)Signal transduction (limited, e.g., β2-adrenergic receptor signaling)
03

Disease associations

Hemolytic anemias (e.g., hereditary spherocytosis, hereditary elliptocytosis, hereditary stomatocytosis)Immune disorders (autoimmune hemolytic anemia, alloimmunization)Infectious diseases (malaria, via Duffy antigen and membrane composition)Other erythrocyte membrane disorders (paroxysmal nocturnal hemoglobinuria, McLeod syndrome)
04

Safety considerations

Alloimmunization (transfusion incompatibility)Autoimmunity (antibody-mediated hemolysis)Drug-induced hemolytic anemia (for drugs targeting or binding red cell surface)Off-target toxicity (if broadly targeting red cell surface)
05

Biomarkers

Blood group antigens (ABO, Rh, Kell, Duffy, etc.)CD markers (e.g., CD235/Glycophorin A)Membrane protein deficiencies (diagnostic for hereditary anemias)

Beyond the preview

Go deeper on Erythrocyte membrane proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Erythrocyte membrane proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call